METABOLIC EFFECTS OF DIFFERENT LIPID-LOWERING THERAPY REGIMENS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK

被引：0
|
作者：
Koshelskaya, O. [1 ]
Sushkova, A. [1 ]
Kravtshenko, E. [1 ]
Suslova, T. [1 ]
机构：
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk Natl Res Med Ctr, Tomsk, Russia
来源：
JOURNAL OF HYPERTENSION | 2017年 / 35卷
关键词：
D O I：
10.1097/01.hjh.0000523535.39716.04
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.12.26
引用
收藏
页码：E193 / E194
页数：2
相关论文
共 50 条
  • [21] Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study
    Amar M. Salam
    Cardiovascular Drugs and Therapy, 2004, 18 : 387 - 389
  • [22] The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients
    Howes, LG
    DIABETES OBESITY & METABOLISM, 2006, 8 (01): : 8 - 14
  • [23] Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
    Bi, Lei
    Yi, Jiayi
    Wu, Chaoqun
    Hu, Shuang
    Zhang, Xingyi
    Lu, Jiapeng
    Liu, Jiamin
    Zhang, Haibo
    Yang, Yang
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Guo, Yuanlin
    Li, Xi
    Zheng, Xin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [24] Lipid-lowering therapy in patients with average cholesterol and high cardiovascular risk, insights from the heart protection study
    Salam, AM
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (05) : 387 - 389
  • [25] Individualized lipid-lowering therapy to further reduce residual cardiovascular risk
    Weingaertner, Oliver
    Luetjohann, Dieter
    Ploesch, Torsten
    Elsaesser, Albrecht
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 169 : 198 - 201
  • [26] Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital
    Spighi, Alessandro
    Tartagni, Elisa
    D'Addato, Sergio
    Dormi, Ada
    Borghi, Claudio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (04) : 270 - 275
  • [27] Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
    Knowles, Joshua W.
    Howard, William B.
    Karayan, Lala
    Baum, Seth J.
    Wilemon, Katherine A.
    Ballantyne, Christie M.
    Myers, Kelly D.
    CIRCULATION, 2017, 135 (22) : 2204 - 2206
  • [28] Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk
    Avogaro, Angelo
    Buzzetti, Raffaella
    Candido, Riccardo
    De Cosmo, Salvatore
    Notarianni, Lucia
    Consolo, Eleonora
    Luciano, Myriam
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 222
  • [29] Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins
    Rauch, U
    Osende, JI
    Chesebro, JH
    Fuster, V
    Vorchheimer, DA
    Harris, K
    Harris, P
    Sandler, DA
    Fallon, JT
    Jayaraman, S
    Badimon, JJ
    ATHEROSCLEROSIS, 2000, 153 (01) : 181 - 189
  • [30] Aortopathy: Effects of Lipid-Lowering Therapy
    Vollaro, Matthew
    Sharma, Tanya
    Sharma, Mala
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2025, 33 (01) : 82 - 87
12345